Search Within

Joachim Yahalom

  1. "Hematological Oncology"
Formats
  1. Meeting Abstract (33)
  2. Journal Article (1)
Groups
  1. Radiation Oncology, Department of (34)
  2. Survivorship Research (34)
  3. Department of Medicine (24)
  4. Hematologic Malignancies, Division of (24)
  5. Center for Hematologic Malignancies (20)
  6. GME, Radiation Oncology (15)

More Groups

People
  1. Brandon Imber (21)
  2. Carla Hajj (15)
  3. Beatrice Fregonese (11)
  4. Maria Palomba (10)
  5. Andrew Zelenetz (9)
  6. Gilles Salles (9)

More People

Years
  1. 2023 (20)
  2. 2021 (2)
  3. 2019 (7)
  4. 2017 (5)
Publications
  1. Hematological Oncology (34)
Publishers
  1. Wiley Blackwell (34)

Results (34)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Low grade, indolent lymphomas of the head and neck: Comparative toxicity of standard versus very low dose radiation therapy
    Journal Article

    Chelius, M.; Chau, K.; Yang, J.; Hajj, C.; Imber, B.; Yahalom, J.
    Hematological Oncology (2021)

    Fulltext@MSK | Save
  • Clinical outcomes and the role of observation in early‐stage follicular lymphoma
    Meeting Abstract

    Sha, F.; Okwali, M.; Alperovich, A.; Caron, P. C.; Falchi, L.; Hamilton, A.; Hamlin, P. A.; Horwitz, S. M.; Joffe, E.; Kumar, A.; more...
    Hematological Oncology (2021)

    Fulltext@MSK | Save
  • Grade 3A follicular lymphoma can be effectively controlled with very low dose radiation therapy
    Meeting Abstract

    Imber, B. S.; Chau, K.; Goldberg, E.; Joffe, E.; Yahalom, J.
    Hematological Oncology (2019)

    Fulltext@MSK | Save
  • Safety and early data from a phase II trial of pembrolizumab (PEM) and entinostat (ENT) in relapsed and refractory (R/R) Hodgkin lymphoma (Hl) and follicular lymphoma (FL)
    Meeting Abstract

    Sermer, D.; Vardhana, S.; Batlevi, C.; Hamilton, A.; Moskowitz, A.; Caron, P.; Moskowitz, C.; Matasar, M.; Biggar, E.; Leung, E.; more...
    Hematological Oncology (2019)

    Fulltext@MSK | Save
  • Highly favorable outcomes with RT followed by ASCT in low/low‐intermediate secondary age adjusted IPI rel/ref DLBCL patients refractory to salvage chemotherapy
    Meeting Abstract

    Yang, J. C.; Chau, K. W.; Scordo, M.; Sauter, C. S.; Yahalom, J.
    Hematological Oncology (2019)

    Fulltext@MSK | Save
  • MSKCC early experience using radiotherapy as a bridging strategy for relapsed diffuse large B cell lymphoma before CD19 CAR T therapy
    Meeting Abstract

    Imber, B. S.; Palomba, M. L.; DeSelm, C.; Batlevi, C.; Dahi, P. B.; Giralt, S.; Noy, A. M.; Park, J. H.; Sauter, C. S.; Scordo, M.; more...
    Hematological Oncology (2019)

    Fulltext@MSK | Save
  • Incidence and treatment outcomes of patients with transformed marginal zone lymphoma treated with RCHOP‐like regimens
    Meeting Abstract

    Rajeeve, S.; Bobillo, S. V.; Zelenetz, A. D.; Straus, D. J.; Palomba, M. L.; Noy, A.; Horwitz, S. M.; Moskowitz, A. J.; Hamlin, P. A.; Matasar, M. J.; more...
    Hematological Oncology (2019)

    Fulltext@MSK | Save
  • Clinical characteristics and outcomes of stage I diffuse large B cell lymphoma (DLBCL) in the rituximab‐era
    Meeting Abstract

    Bobillo, S.; Joffe, E.; Lavery, J.; Noy, A.; Palomba, L.; Straus, D. J.; Kumar, A.; Batlevi, C.; Horwitz, S.; Moskowitz, A.; more...
    Hematological Oncology (2019)

    Fulltext@MSK | Save
  • Outcomes of 180 patients with indolent lymphomas treated with very low dose (4 Gy) radiation therapy alone
    Meeting Abstract

    Chau, K. W.; Imber, B. S.; Joffe, E.; Yang, J. C.; Chelius, M. R.; Doyle, C. J.; Hajj, C.; Yahalom, J.
    Hematological Oncology (2019)

    Fulltext@MSK | Save
  • Langerhans cell histiocytosis in adults is associated with increased hematologic and solid malignancies
    Meeting Abstract

    Ma, J.; Laird, J.; Chau, K.; Chelius, M.; Bell, A. C.; Zhang, Z.; Lok, B. H.; Yahalom, J.
    Hematological Oncology (2017)

    Fulltext@MSK | Save